2023
DOI: 10.1097/coa.0000000000000006
|View full text |Cite
|
Sign up to set email alerts
|

Treatment Trials for Viral Conjunctivitis: What We Have Learned and How We can Improve

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 19 publications
0
1
0
Order By: Relevance
“…Because viral etiology is thought to be predominant in cases of conjunctivitis in the United States, indiscriminate dispensing of antibiotic eyedrops for conjunctivitis in the United States may be inappropriate. 3 , 29 , 30 However, testing for pathogen identification is not performed routinely for conjunctivitis in any location. Thus, targeted treatment toward definitively identified pathogens is rarely possible.…”
Section: Discussionmentioning
confidence: 99%
“…Because viral etiology is thought to be predominant in cases of conjunctivitis in the United States, indiscriminate dispensing of antibiotic eyedrops for conjunctivitis in the United States may be inappropriate. 3 , 29 , 30 However, testing for pathogen identification is not performed routinely for conjunctivitis in any location. Thus, targeted treatment toward definitively identified pathogens is rarely possible.…”
Section: Discussionmentioning
confidence: 99%